» Articles » PMID: 22282664

Ultrasound Increases Nanoparticle Delivery by Reducing Intratumoral Pressure and Increasing Transport in Epithelial and Epithelial-mesenchymal Transition Tumors

Overview
Journal Cancer Res
Specialty Oncology
Date 2012 Jan 28
PMID 22282664
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Acquisition of the epithelial-mesenchymal transition (EMT) tumor phenotype is associated with impaired chemotherapeutic delivery and a poor prognosis. In this study, we investigated the application of therapeutic ultrasound methods available in the clinic to increase nanotherapeutic particle accumulation in epithelial and EMT tumors by labeling particles with a positron emission tomography tracer. Epithelial tumors were highly vascularized with tight cell-cell junctions, compared with EMT tumors where cells displayed an irregular, elongated shape with loosened cell-cell adhesions and a reduction in E-cadherin and cytokeratins 8/18 and 19. Without ultrasound, the accumulation of liposomal nanoparticles administered to tumors in vivo was approximately 1.5 times greater in epithelial tumors than EMT tumors. When ultrasound was applied, both nanoaccumulation and apparent tumor permeability were increased in both settings. Notably, ultrasound effects differed with thermal and mechanical indices, such that increasing the thermal ultrasound dose increased nanoaccumulation in EMT tumors. Taken together, our results illustrate how ultrasound can be used to enhance nanoparticle accumulation in tumors by reducing their intratumoral pressure and increasing their vascular permeability.

Citing Articles

Engineering Versatile Nanomedicines for Ultrasonic Tumor Immunotherapy.

Liang J, Qiao X, Qiu L, Xu H, Xiang H, Ding H Adv Sci (Weinh). 2023; 11(3):e2305392.

PMID: 38041509 PMC: 10797440. DOI: 10.1002/advs.202305392.


Solid tumor treatment via augmentation of bioactive C6 ceramide levels with thermally ablative focused ultrasound.

Thim E, Fox T, Deering T, Vass L, Sheybani N, Kester M Drug Deliv Transl Res. 2023; 13(12):3145-3153.

PMID: 37335416 PMC: 11423265. DOI: 10.1007/s13346-023-01377-w.


Solid Tumor Treatment via Augmentation of Bioactive C6 Ceramide Levels with Thermally Ablative Focused Ultrasound.

Thim E, Fox T, Deering T, Vass L, Sheybani N, Kester M bioRxiv. 2023; .

PMID: 36993445 PMC: 10055354. DOI: 10.1101/2023.03.23.532394.


Large-Volume Focused-Ultrasound Mild Hyperthermia for Improving Blood-Brain Tumor Barrier Permeability Application.

Chan H, Chang H, Lin W, Chen G Pharmaceutics. 2022; 14(10).

PMID: 36297445 PMC: 9610093. DOI: 10.3390/pharmaceutics14102012.


Ultrasound-Targeted Microbubble Destruction: Modulation in the Tumor Microenvironment and Application in Tumor Immunotherapy.

Han Y, Sun J, Wei H, Hao J, Liu W, Wang X Front Immunol. 2022; 13:937344.

PMID: 35844515 PMC: 9283646. DOI: 10.3389/fimmu.2022.937344.


References
1.
Wu F, Wang Z, Lu P, Xu Z, Chen W, Zhu H . Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol. 2004; 30(9):1217-22. DOI: 10.1016/j.ultrasmedbio.2004.08.003. View

2.
Seo J, Zhang H, Kukis D, Meares C, Ferrara K . A novel method to label preformed liposomes with 64Cu for positron emission tomography (PET) imaging. Bioconjug Chem. 2008; 19(12):2577-84. PMC: 2756669. DOI: 10.1021/bc8002937. View

3.
Rygh C, Qin S, Seo J, Mahakian L, Zhang H, Adamson R . Longitudinal investigation of permeability and distribution of macromolecules in mouse malignant transformation using PET. Clin Cancer Res. 2010; 17(3):550-9. PMC: 3107124. DOI: 10.1158/1078-0432.CCR-10-2049. View

4.
Dreher M, Liu W, Michelich C, Dewhirst M, Yuan F, Chilkoti A . Tumor vascular permeability, accumulation, and penetration of macromolecular drug carriers. J Natl Cancer Inst. 2006; 98(5):335-44. DOI: 10.1093/jnci/djj070. View

5.
Lin Y, Samardzic H, Adamson R, Renkin E, Clark J, Reed R . Phosphodiesterase 4 inhibition attenuates atrial natriuretic peptide-induced vascular hyperpermeability and loss of plasma volume. J Physiol. 2010; 589(Pt 2):341-53. PMC: 3043537. DOI: 10.1113/jphysiol.2010.199588. View